Real-time disaster intelligence, alerts, and response tools.
Wednesday, April 22, 2026
[ad_1] CAMBRIDGE, Mass., Nov. 26, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, […]
[ad_1] NEW YORK, Nov. 26, 2025 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced that Daniel Vitt, Ph.D., Chief Executive Officer of […]
[ad_1] – In a Phase 3 clinical study evaluating the efficacy and safety of sparsentan in Japanese patients with IgA nephropathy (N=35), the percent change from baseline in the 24-hour urine protein-to-creatinine ratio at Week […]
[ad_1] MOORESVILLE, N.C., Nov. 25, 2025 /PRNewswire/ — Lowe’s Companies, Inc. (NYSE: LOW) announces that Marvin R. Ellison, chairman and chief executive officer, will participate in a fireside chat at the Morgan Stanley Global Consumer […]
[ad_1] LAKE OSWEGO, Ore., Nov. 25, 2025 /PRNewswire/ — The Greenbrier Companies, Inc. (NYSE:GBX) will be presenting on Thursday, December 4, 2025, at the Goldman Sachs Industrials and Materials Conference to be held in New York City. […]
